Latest news
EU Approves Sanofi's MenQuadfi for Infants as Young as 6 Weeks, Expanding Protection Against a Leading Cause of Acquired Deafness - The Hearing ReviewThe Hearing Review · Fri, 07 Aug 2026 00:18:45 GMTMeningococcal B vaccine linked to lower gonorrhoea risk - News-MedicalNews-Medical · Thu, 06 Aug 2026 12:29:00 GMTNHS begins catch-up campaign for MenB Vaccine - Open Access GovernmentOpen Access Government · Wed, 05 Aug 2026 15:08:11 GMTMeningococcal B vaccine linked to lower gonorrhea risk - Medical XpressMedical Xpress · Wed, 05 Aug 2026 12:20:04 GMTSanofi’s MenQuadfi approval expanded to infants from six weeks in Europe - European Pharmaceutical ReviewEuropean Pharmaceutical Review · Tue, 04 Aug 2026 13:39:01 GMTSanofi’s MenQuadfi approved in the EU for younger infants - The Pharma LetterThe Pharma Letter · Tue, 04 Aug 2026 10:26:53 GMTPress Release: Sanofi’s MenQuadfi approved in the EU for - GlobeNewswireGlobeNewswire · Tue, 04 Aug 2026 05:00:00 GMTPandemic reshapes meningococcal strains in Scotland, with group B dominating cases - Medical XpressMedical Xpress · Mon, 27 Jul 2026 07:00:00 GMT